Medication-info.com Search Menu

Jascayd (Nerandomilast): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
9 mg, 18 mg
Active ingredient:

Patient information: uses, side effects, how to take - Jascayd

What is JASCAYD?

JASCAYD is a prescription medicine used:

  • to treat adults with a lung disease called idiopathic pulmonary fibrosis (IPF).
  • to treat adults with a lung disease called progressive pulmonary fibrosis (PPF).

It is not known if JASCAYD is safe and effective in children.

Before you take JASCAYD, tell your healthcare provider about all of your medical conditions, including if you:

  • have kidney problems.
  • have liver problems.
  • are pregnant or plan to become pregnant. JASCAYD may cause loss of your pregnancy (miscarriage). It is not known if JASCAYD can harm your unborn baby. Tell your healthcare provider right away if you become pregnant or think you are pregnant while taking JASCAYD.

  • are breastfeeding or plan to breastfeed. It is not known if JASCAYD passes into your breastmilk. You and your healthcare provider should decide if you will take JASCAYD or breastfeed.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. JASCAYD may affect the way other medicines work, and other medicines may affect how JASCAYD works. Know the medicines you take. Keep a list of them and show it to your healthcare provider or pharmacist when you get a new medicine.

How should I take JASCAYD?

  • Take JASCAYD exactly as your healthcare provider tells you to take it.
  • Your healthcare provider will tell you how much JASCAYD to take and when to take it.
  • Take JASCAYD either with or without food.

  • Swallow JASCAYD tablets whole.
  • If you cannot swallow JASCAYD tablets whole:

    • Place 3 to 4 ounces (about 100 mL) of non-carbonated, room temperature water in a glass. Do not use any other liquids.
    • Place a JASCAYD tablet in the water, without crushing the tablet, and stir regularly for about 15 to 20 minutes until the tablet is in very small pieces (the tablet will not completely dissolve).
    • Drink the JASCAYD and water mixture within 2 hours of mixing.
    • If you do not drink the mixture right away, stir the mixture again before drinking.
    • Rinse the glass with 3 to 4 ounces (about 100 mL) of water and drink to make sure that you have taken the full dose of JASCAYD.
  • If you miss a dose of JASCAYD, take your next dose at your regular time. Do not take the missed dose.
  • Do not take more than two 18 mg JASCAYD tablets in 1 day.
  • If you take too much JASCAYD, call your healthcare provider or Poison Help line at 1-800-222-1222, or go to the nearest hospital emergency room right away.

What are the possible side effects of JASCAYD?

The most common side effects of JASCAYD include:

  • diarrhea
  • COVID-19
  • upper respiratory tract infection
  • depression
  • weight loss
  • decreased appetite
  • nausea
  • fatigue
  • headache
  • vomiting
  • back pain
  • dizziness

These are not all of the possible side effects of JASCAYD. For more information, ask your healthcare provider or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store JASCAYD?

  • Store JASCAYD at room temperature between 68°F to 77°F (20°C to 25°C).
  • Store JASCAYD in the original child-resistant container to protect it from light.

Keep JASCAYD and all medicines out of the reach of children.

General information about the safe and effective use of JASCAYD.

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use JASCAYD for any condition for which it was not prescribed. Do not give JASCAYD to other people, even if they have the same symptoms you have. It may harm them. You can ask your healthcare provider or pharmacist for information about JASCAYD that is written for health professionals.

What are the ingredients in JASCAYD?

Active ingredient: nerandomilast

Inactive ingredients: croscarmellose sodium, ferric oxide red (18 mg tablets only), ferric oxide yellow (9 mg tablets only), ferrosoferric oxide (18 mg tablets only), hydroxypropyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, mannitol, microcrystalline cellulose, polyethylene glycol, and talc. Each tablet contains less than 5 mg of sodium.

Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA

Licensed from: Boehringer Ingelheim International GmbH, Ingelheim, Germany

JASCAYD is a registered trademark of and used under license from Boehringer Ingelheim International GmbH.

Copyright © 2025 Boehringer Ingelheim International GmbH ALL RIGHTS RESERVED

COL11694CL182025

For more information about JASCAYD, including current Prescribing Information and patient support, go to www.jascayd.com or call Boehringer Ingelheim Pharmaceuticals, Inc. at 1-800-542-6257, or scan the code to go to www.jascayd.com.

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: NDA 218764 · View the label on DailyMed

Revision date stated in the text: December 2025

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Jascayd

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Active ingredient Nerandomilast
Dosage form Tablet, film coated
Route Oral
Marketing status listed in the FDA NDC Directory
Company (applicant) BOEHRINGER INGELHEIM
FDA approval NDA 218764New Drug Application (NDA) Approved October 7, 2025
Reference listed drug This is the reference listed drug (RLD) that generics are compared with.
Manufacturers 1 labelers list this drug on DailyMed
Packages (NDC)
Package
9 mg – 60 in 1 bottle, plastic / 1 in 1 carton NDC 0597-2465-41
18 mg – 60 in 1 bottle, plastic / 1 in 1 carton NDC 0597-7313-21

Source: FDA drug labeling via NLM DailyMed, data as of October 31, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.